Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | THC | BSP |
|---|---|---|
| Price | $254.77 | $32.69 |
| Change today | ▼ 0.31% | ▼ 1.89% |
| Market cap | $20.51B | $20.77B |
| Return, 3 months | +33.2% | -19.3% |
| Return, year to date | +28.2% | – |
| Return, 1 year | +26.5% | – |
| P/E (TTM) | 9.8 | 82.8 |
| P/B | 4.4 | 16.5 |
| P/E percentile vs own 5y | 46th | 44th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +14.6% | +126.3% |
| Net profit growth (YoY) | +100.2% | +171.2% |
| Gross margin | 82.8% | 67.1% |
| Operating margin | 19.5% | 23.1% |
| Net margin | 9.9% | 8.2% |
| Return on equity | 53.3% | 21.8% |
| Analyst target vs. price | +11.2% | +38.4% |
| Analyst buy share | 89% | 50% |
| RSI (14) | 46 | 37 |
| 30-day volatility | 29.0% | 62.8% |
| Max drawdown, 1 year | -34.1% | -38.7% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
